IBRN ETF

IBRN ETF
$38.94
See how much of IBRN you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
-5.99%
3 Months
+6.00%
6 Months
+12.21%
YTD
+13.18%
1 Year
+58.32%
3 Years (annualized)
+14.63%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would IBRN have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
NYSE FactSet Global Neuro Biopharma and MedTech Index(NYFSNBMT)
This ETF (YTD)
+13.18%
Peer Avg (YTD)
+6.74%
vs Peers
+6.44%

IBRN ETF Performance

IBRN performance across multiple time periods: 1-month -5.99%, YTD 13.18%, 1-year 58.32%, 3-year 14.63%.

IBRN returns outperform the peer average of 6.74% YTD. With an expense ratio of 0.47%, investors should weigh costs against performance when evaluating this ETF.

IBRN vs another fund shows side-by-side returns. IBRN alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-5.99%N/A
3 Months+6.00%N/A
6 Months+12.21%N/A
1 Year+58.32%N/A
3 Years+14.63%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized